Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. Thirty-four patients with cancer pain and no previous opioid treatment were randomized to receive morphine hydrochloride ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results